Michael Endres
8Patents
4h-index
12Co-inventors
50Inventor score
Filing activity: Nov 7, 2001 → Mar 15, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9259459B2 | Antibody vaccine conjugates and uses therefor | Emerging Cross-Sectional Technologies | 21 | Active |
| US7560534B2 | Molecular conjugates comprising human monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 20 | Expired |
| US7763258B2 | Virus-like particles (VLPs) comprising heterologous multiple membrane spanning proteins | Chemistry; Metallurgy | 7 | Expired |
| US8158130B2 | Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins | Chemistry; Metallurgy | 5 | Active |
| US8142790B2 | Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 2 | Active |
| US9095626B2 | Monoclonal antibodies to dendritic cells | Chemistry; Metallurgy | 0 | Active |
| US9243064B2 | Antibody vaccine conjugates and uses therefor | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8680244B2 | Method for the production of antibodies that bind to multiple membrane spanning proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.